Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Dyne Therapeutics Inc (NASDAQ: DYN) closed at $29.28 in the last session, down -4.34% from day before closing price of $30.61. In other words, the price has decreased by -$4.34 from its previous closing price. On the day, 0.7 million shares were traded. DYN stock price reached its highest trading level at $30.46 during the session, while it also had its lowest trading level at $29.26.
Ratios:
We take a closer look at DYN’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 17.02 and its Current Ratio is at 17.02. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, RBC Capital Mkts on November 26, 2024, initiated with a Outperform rating and assigned the stock a target price of $45.
On October 24, 2024, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $43 to $35.
Chardan Capital Markets reiterated its Buy rating for the stock on May 21, 2024, while the target price for the stock was revised from $31 to $42.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 25 ’24 when McNeill Jonathan bought 19,987 shares for $29.69 per share.
Forbion Capital Fund IV Cooper bought 62,301 shares of DYN for $1,869,030 on Nov 22 ’24. On Nov 18 ’24, another insider, Incerti Carlo, who serves as the Director of the company, sold 16,500 shares for $28.73 each. As a result, the insider received 474,045 and left with 0 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DYN now has a Market Capitalization of 2979708672 and an Enterprise Value of 2280891136.
Stock Price History:
Over the past 52 weeks, DYN has reached a high of $47.45, while it has fallen to a 52-week low of $10.33. The 50-Day Moving Average of the stock is -7.42%, while the 200-Day Moving Average is calculated to be -10.06%.
Shares Statistics:
According to the various share statistics, DYN traded on average about 1.31M shares per day over the past 3-months and 1048460 shares per day over the past 10 days. A total of 101.75M shares are outstanding, with a floating share count of 77.00M. Insiders hold about 25.47% of the company’s shares, while institutions hold 86.85% stake in the company. Shares short for DYN as of 1731628800 were 10152544 with a Short Ratio of 7.77, compared to 1728950400 on 9110273. Therefore, it implies a Short% of Shares Outstanding of 10152544 and a Short% of Float of 11.85.
